These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1903901)

  • 1. The impact of the Rx to OTC switch on practicing pharmacists.
    Palumbo FB
    Am Pharm; 1991 Apr; NS31(4):41-4. PubMed ID: 1903901
    [No Abstract]   [Full Text] [Related]  

  • 2. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
    Emmerton L
    J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription to over-the-counter switch: a regulatory perspective.
    Juhl RP
    Clin Ther; 1998; 20 Suppl C():C111-7. PubMed ID: 9915097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPIs: community pharmacists' compliance.
    Kaczmarek ER; Stewart JE; Hutchinson RA
    Drug Intell Clin Pharm; 1981 Feb; 15(2):117-9. PubMed ID: 7274018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
    Spencer HM
    Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
    [No Abstract]   [Full Text] [Related]  

  • 7. From Rx to OTC: more drugs make the switch.
    Marwick C
    JAMA; 1997 Jul; 278(2):103. PubMed ID: 9214514
    [No Abstract]   [Full Text] [Related]  

  • 8. The community pharmacist: health sentinel on the home front.
    Gervasi P
    Am J Public Health; 1974 Aug; 64(8):811-2. PubMed ID: 4835148
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine.
    Chanda S; Sansgiry SS
    J Am Pharm Assoc (2003); 2008; 48(1):52-7. PubMed ID: 18192131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking chance out of the Rx-OTC switch.
    Murphy DH
    Am Pharm; 1985 Jan; NS25(1):41-5. PubMed ID: 3969850
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
    Sullivan PW; Nair KV; Patel BV
    Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rx--OTC. New resources in self-medication.
    Doluisio JT
    Am Pharm; 1983 Jan; NS23(1):26-8. PubMed ID: 6823828
    [No Abstract]   [Full Text] [Related]  

  • 13. [Issues and Prospects from the OTC Industry vis a vis Pharmaceutical Education and OTC Medicines].
    Nishizawa M
    Yakugaku Zasshi; 2016; 136(7):955-63. PubMed ID: 27374957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The public health problem of OTC antibiotics in developing nations.
    Khalid L; Mahsood N; Ali I
    Res Social Adm Pharm; 2016; 12(5):801-2. PubMed ID: 27067233
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of over-the-counter medicines’ information and strategies oriented to the community for improving its access and quality.].
    Armando PD; Moscardó MN; Tenllado MI; Uema SAN
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):248-254. PubMed ID: 30734703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of over-the-counter drugs: the FDA's OTC drug review.
    Pediatrics; 1977 Feb; 59(2):309-11. PubMed ID: 834521
    [No Abstract]   [Full Text] [Related]  

  • 18. Marketing your nonprescription drug department.
    Murphy D
    Am Pharm; 1985 Jul; NS25(7):38-41. PubMed ID: 4036804
    [No Abstract]   [Full Text] [Related]  

  • 19. Attitudes towards sales and use of over-the-counter drugs in Sweden in a reregulated pharmacy market: a population-based study.
    Hedenrud T; Andersson Sundell K; Martinsson J; Håkonsen H
    Int J Pharm Pract; 2019 Feb; 27(1):17-24. PubMed ID: 29687513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a third class of drugs in pharmacy's future?
    Martin S
    Am Pharm; 1991 Apr; NS31(4):36-40. PubMed ID: 2038961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.